Barbara Ann Karmanos Cancer Institute

This study tests whether a device called TheraBionic P1, which delivers targeted radio waves, can help shrink early-stage breast cancer before surgery. About 24 women with hormone receptor-positive, HER2-negative breast cancer will use the device daily for a short time before the…

This study tests whether adding a non-invasive radiofrequency treatment (AM RF EMF) to the drug fruquintinib can help people with metastatic colorectal cancer that has stopped responding to standard therapies. About 102 adults will receive both treatments to see if it improves su…

This study is for people with advanced liver cancer that has come back or spread, and who have already tried at least two standard treatments without success. The goal is to see if using a device called TheraBionic P1 can help them live longer and improve their quality of life. P…

This study tests whether adding a special device that delivers amplitude-modulated radiofrequency electromagnetic fields (AM RF EMF) to standard chemotherapy can help people with metastatic pancreatic cancer. About 30 participants will receive the combination treatment. The main …

This study is testing a special PET/CT scan that uses a form of tryptophan (a building block of protein) to see if it can make tumors stand out more clearly from healthy tissue. About 24 adults with certain brain, breast, neuroendocrine, or rectal cancers will get this scan. The …

This study looks at whether a high-intensity CrossFit program can help cancer survivors improve their physical function, body composition, and quality of life more than standard exercise guidelines. Researchers will enroll 500 adult cancer survivors who have medical clearance to …

This study tests a new tattoo ink called Magic Ink that fades over time, used to mark the exact spot for daily radiation in women with breast cancer. About 30 women will get the Magic Ink instead of standard permanent ink. Researchers will check if it's safe and if it stays visib…

This early-phase study is testing whether adding metformin (a common diabetes medicine) to standard chemotherapy or immunotherapy is safe for people with advanced solid tumors. About 60 adults will take metformin alone for two weeks, then continue it alongside their regular cance…

This study works with community leaders and genetic experts to create an online education program for African American cancer survivors. The goal is to help more people understand and choose genetic counseling and testing. About 85 participants from Detroit will try the program a…